Early vs. Late HAART for HIV Patients with Tuberculosis
Author Information
Author(s): François-Xavier Blanc, Sok Thim, Laureillard Didier, Borand Laurence, Rekacewicz Claire, Nerrienet Eric, Madec Yoann, Marcy Olivier, Chan Sarin, Prak Narom, Kim Chindamony, Kim Lak Khemarin, Hak Chanroeurn, Dim Bunnet, Im Sin Chhun, Sun Sath, Guillard Bertrand, Sar Borann, Vong Sirenda, Fernandez Marcelo, Fox Lawrence, Delfraissy Jean-François, Goldfeld Anne E
Primary Institution: Institut Pasteur International Network
Hypothesis
Does early initiation of HAART improve survival in severely immunosuppressed HIV-infected adults with tuberculosis compared to late initiation?
Conclusion
Starting HAART 2 weeks after TB treatment significantly improves survival in severely immunosuppressed HIV-infected adults.
Supporting Evidence
- 661 patients were enrolled in the study.
- 149 patients were known dead by May 13, 2010.
- Enhanced survival was observed in the early treatment group.
Takeaway
If you start HIV treatment sooner after getting tuberculosis, you are more likely to survive.
Methodology
Open-labelled randomized clinical trial comparing early vs. late HAART initiation after TB treatment in treatment-naïve adults.
Participant Demographics
Median age of 35 years, CD4+ cell count ≤ 200 cells/mm3.
Statistical Information
P-Value
0.004
Statistical Significance
p=0.004
Want to read the original?
Access the complete publication on the publisher's website